Sina Djali will join the ranks of the Triall initiative as advisor Clinical Trial Data Analytics. Sina has over 25 years of experience in drug and clinical development in various...Read More
We are excited to announce the world’s first clinical trial on the blockchain. A beta version of the foundation’s Verial software application was given green light for use in a real-world...Read More
A steady and efficient influx of novel medical solutions is critical for meeting society’s current and future medical needs. The clinical research industry is responsible for the delivery of these...Read More
Triall today announces that it has received funding as part of the second Factom grant round of 2019. It will use these funds to develop a Factom-enabled Decentralized Identifier (DID)...Read More
Biopharmaceutical companies, Contract Research Organizations (CROs) and research sites are increasingly using clinical trial IT (‘eClinical’) solutions to smoothen and optimize the management and conduct of their clinical trial activities....Read More
The National eHealth Living Lab (NeLL) originated in the Leiden University Medical Center and is one of the main partners of Triall. At NeLL, patients, healthcare professionals, consumers, students, scientists,...Read More
Triall today announces that it will be presenting at the ClinOpsDag 2019 (‘Clinical Operations Day’) event on the 15th of May. As part of the event, Joost Flach, Triall’s director...Read More
Triall announces the official release of the Triall whitepaper. This document outlines the foundation’s vision and plans for building towards the world’s first multisided clinical trial platform that is open to...Read More
Triall today announces that it has been awarded a Seal of Excellence by the European Commission (EC) as the institution managing Horizon 2020, the EU Framework Program for Research and...Read More
Triall today announces that it has been featured in a video explaining the Factom Asset Token protocol (FAT). FAT is an open-source tokenization protocol build on top of the Factom...Read More
